Q Based on readings by Freeman in Leaf et al. (2008), Normand (2008), Elder (2008), Lerman et al. (2008), Navarro et al. (2015), Smith (2005), & Zane (2005) 1) Why is it important to be a skeptic? 2) Why are unvalidated treatments so appealing? 3) What are at least 3 questions we should be asking to evaluate treatments? 4) What do the Lerman et al. results mean for clinical practice? 5) How can we minimize the use of treatments that are not evidence-based?
View Related Questions